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Background: Transanal total mesorectal excision (TaTME) is emerging as a novel alternative 
to laparoscopic total mesorectal excision (LaTME). The aim of this study was to compare clini-
cal and pathological results from these two techniques in patients undergoing rectal resections 
because of low rectal cancer.
Materials and methods: Thirty-five patients undergoing TaTME were matched with 35 
patients operated on using LaTME. Composite primary endpoint (complete TME, negative 
circumferential resection margin [pCRM], and distal resection margin [pDRM]) was used to 
assess pathological quality specimens. Secondary outcomes included operative and postopera-
tive parameters (operative time, total blood loss, postoperative morbidity, length of stay, 30-day 
mortality).
Results: Composite primary endpoint was achieved by 85% of subjects in the TaTME group 
and 82% of subjects in the LaTME group (P=0.66). Mean pCRM was 1.1±1.29 vs 0.99±0.78 
mm (P=0.25). Distal pDRM was 1.57±0.92 and 1.98±1.22 cm (P=0.15). In the TaTME and 
LaTME groups, respectively, complete mesorectal excision was achieved in 89% and 83% of 
subjects, while excision was nearly complete for the remaining 11% and 17% (P=0.23).
Conclusion: TaTME appears to be a noninferior alternative to laparoscopic surgery. TaTME 
allows for quality retrieval of surgical specimens with comparable clinical outcomes with LaTME.
Keywords: transanal TME, laparoscopic TME, rectal cancer, low rectal cancer, minimally 
invasive surgery
Background
Treatment results in rectal cancer patients depend strongly on the quality of surgery; 
therefore, successful oncologic resection requires complete mesorectal excision 
without injury to the mesorectal fascia and with preservation of adequate distal and 
radial margins and adequate lymphadenectomy.1–4 Regardless of the surgical access 
method, the procedure itself  is challenging (particularly in obese male patients), 
requires substantial expertise, and final outcomes in the global patient population 
are suboptimal.5,6 The oncological safety of laparoscopic surgery has been proven in 
randomized control trials (RCTs); therefore, it could be treated as a reference as well 
as an open approach.7,8 Laparoscopic surgery of the rectum, which has been performed 
for more than two decades, has reached a similar level of efficacy and is regarded, 
at the minimum, as noninferior to open operation.8–13 Both techniques—open and 
laparoscopic—have been standardized and are considered equivalent. However, they 
may have reached their maximum levels of efficacy, and a substantive improvement in 
treatment results through refinement of the existing methods is unlikely. This plateau, 
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observed for several years, has prompted a search for more 
effective methods to increase the quality of mesorectal 
excision. By application of the perineal approach in 
intersphinteric resection, Rullier pioneered sphincter-saving 
surgery in low rectal tumors.14 Expectations have recently 
risen with introduction of the transanal (or hybrid) approach, 
referred to as transanal total mesorectal excision (TaTME).15 
The method itself appears highly promising, particularly 
for patients with cancer located in the lower rectum, where 
technical difficulties are the most severe, and the risk of 
permanent stoma is highest.16 TaTME is also expected to 
diminish the conversion rate and risk of specimen perforation. 
Moreover, it was recently reported that quality pathological 
specimens have been retrieved following TaTME.17–20 
However, full evaluation of this technique requires long-
lasting, well-designed, and properly performed prospective 
trials. Unfortunately, ongoing studies are not expected to be 
completed for several years.5 This prompted us to undertake a 
case-matched study based on our own experience, to compare 
laparoscopic TME (LaTME) and TaTME with regard to the 
surgical quality of low rectal cancer resection. Aim of the 
study is to compare short-term clinical and pathological 
outcomes of TaTME and LaTME in low rectal cancer.
Materials and methods
setting and design
All procedures were performed in a tertiary referral university 
hospital participating in the COLOR III RCT. The annual 
volume in our unit is around 120 colorectal procedures, 50 
of which involve rectal resections. The TaTME procedure 
was implemented in 2014. Patients with cancer of the lower 
rectum (<5 cm from the anal verge) and who underwent 
surgery via TaTME were included in group 1. Patients 
from the TaTME group were matched with patients who 
underwent LaTME (group 2). Matching was done by an 
independent administrative officer, for age, body mass index 
(BMI), sex, distance of the tumor from the anal verge, and 
stage of the disease. To avoid potential bias, the officer was 
not made aware of the study concept. All surgeons in our 
team with expert skills in laparoscopic surgery participated 
in a hands-on cadaver TaTME course before performing 
the TaTME procedure on our patients. The first 10 TaTME 
cases performed at our institution were excluded from the 
analysis to reduce the bias during the learning curve for 
the operation. The same experienced pathologist assesses 
all specimens in accordance with a classification derived 
by Quirke et al.21,22 Nearly complete mesorectal excision 
was defined as defects <5 mm in the mesorectal fascia. R1 
resection margin was defined as a radial or distal margin <1 
mm. Complete mesorectal excision was defined as no defects
in the mesorectal fascia.
Patients
Prospective collection of data from patients undergoing 
TaTME surgery for low (<5 cm from the anal verge) rectal 
adenocarcinoma was performed between January 2015 and 
January 2018. A control LaTME group was from 2012 to 
2014, when LaTME was a standard procedure for treating 
low rectal cancer at our clinic. The protocol of treatment, 
including chemoradiotherapy and perioperative care, did not 
change during the study duration. Patients initially admitted 
for abdominoperineal resection and end colostomy were 
excluded from the analysis. Patients included in the group 
were not participants in the COLOR III trial. All procedures 
were performed by one of surgeons with expert skills in 
colorectal surgery procedures. Patients were submitted for 
preoperative chemoradiotherapy when clinically indicated 
(T3 or positive lymph nodes in preoperative MRI staging). 
We routinely use a long course of chemoradiotherapy, which 
consists of 50.4 Gy combined with chemotherapy followed 
by surgery after 8 weeks. Preopretive chemoradiotherapy 
was indicated in 31 patients in each group. In LaTME 
group, 18 patients had cT3 stage alone as an indication for 
radiotherapy, 6 had cT3N+, 6 had cT2N+, and 1 cT1N+. In 
TaTME group, 17 patients had cT3 alone, 6 had cT3N+, 7 had 
cT2N+, and 1 had cT1N+. Four patients in LaTME and five 
patients in TaTME had <2 mm magnetic resonance imaging 
circumferencial resection margin (circumferential resection 
margin [pCRM]); they were reevaluated before the surgery. 
In these patients, we managed to achieve downstaging before 
the surgery; thus there were no suspicion of mesorectal fascia 
infiltration. Perioperatively, all patients were treated in accor-
dance with the Enhanced Recovery after Surgery (ERAS) 
protocol, which is a standard for care at our institution.23–25
Measured outcomes
The primary outcome was a composite endpoint defined as 
negative pCRM, negative distal resection margin (pDRM), 
and complete mesorectal excision. Secondary outcomes were 
operative and postoperative parameters (operative time, total 
blood loss, postoperative morbidity, length of stay, 30-day 
mortality). Postoperative morbidity was assessed using 
Clavien–Dindo classification.26 Serious complications were 
defined as Clavien–Dindo III–V.
Operative technique
The operative technique used is detailed elsewhere.27 We 
routinely use a Karl Storz TEO® platform as an optimization 
Powered by TCPDF (www.tcpdf.org)
                               1 / 1
Cancer Management and Research 2018:10 submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
5241
Transanal total mesorectal excision for low rectal cancer
of the original technique.17 The procedure is performed 
using a one-team approach. The anastomosis is facilitated 
with a circular stapler, and in selected cases (when 
internal sphincter resection was needed to gain negative 
margin or stapler anastomosis was not possible), coloanal 
anastomosis was performed. No additional procedures 
(ie, coloplasty) were performed within anastomosis. Full 
mobilization of the splenic flexure was done to facilitate 
tension-free anastomosis. Defunctioning ileostomy is 
created routinely.
statistical analysis and ethical approval
All data were analyzed using Statistica version 13.0 PL 
(StatSoft Inc., Tulsa, OK, USA). The results are presented as 
mean and SD, median, and IQR. The chi-squared test of inde-
pendence was used for evaluating categorical variables. The 
Shapiro–Wilk test was used to check for normal distribution 
of data and Student’s t-test was used for normally distributed 
quantitative data. The Mann–Whitney U test was used for 
non-normally distributed quantitative variables. Statistical 
significance was set at P<0.05.
All procedures were performed in accordance with the 
ethical standards of the 1964 Declaration of Helsinki and its 
later amendments (Fortaleza 2013). The study was approved 
by the Local Ethics Committee of the Jagiellonian University 
Medical College. Every patient signed an informed consent 
prior to inclusion in the study.
Results
Table 1 presents demographical characteristics of the study 
group. Composite primary endpoint was reached by 86% of 
the subjects in the TaTME group and 83% in the LaTME 
group (P=0.74). Table 2 summarizes the results.
Patients undergoing TaTME resection had a wider radial 
margin compared with those undergoing standard laparos-
copy, although the data did not reach statistical significance 
(1.41±1.29 vs 0.99±0.78 mm; P=0.25). The distal margin 
was shorter in the TaTME group than the laparoscopy group, 
but again did not reach statistical significance (1.57±0.92 vs 
1.98±1.22 cm; P=0.15).
When using the TaTME technique, complete mesorectal 
excision was achieved in 89% of patients, and in 11%, exci-
sion was nearly complete. For LaTME, 83% had complete 
mesorectal excision and 17% nearly complete resection. 
There were no cases of incomplete mesorectal excision.
Operative time in the TaTME group was significantly 
longer and reached a mean of 271±63 minutes, whereas 
in the LaTME group, the mean time was 219±45 minutes 
(P=0.001). Mean blood loss was 165±148 mL in the TaTME 
group and 113±75 mL in the LaTME group (P=0.07). No 
conversions to an open approach were needed in either 
group. There were two intraoperative complications in the 
LaTME group (one bowel wall perforation with intestinal 
content spillage and one anastomotic leakage identified 
during leak test and that was resolved by adding additional 
sutures) and four in the TaTME group (two anastomotic 
leakages identified intraoperatively, which were solved by 
adding additional sutures in transanal approach and four 
purse-string failures, although none of these patients had 
subsequent abdominal abscess in the postoperative course). 
We managed to perform primary anastomosis in all patients. 
Six patients in the TaTME group and eight in the LaTME 
group suffered from postoperative complications (17% vs 
23%; P=0.21). Three serious complications occurred in 
the TaTME group and four in the LaTME group (9% vs 
12%; P=0.80). We had to create end colostomy in one of 
our patients in the TaTME group as a result of anastomotic 
leakage with septic complications after failed EndoVac® 
management. There were no differences for mean length of 
hospital stay (9.7±10.8 vs 8.8±7.8 days; P=0.71). No 30-day 
Table 1 Demographical characteristics
LaTME TaTME P-value
number of patients 35 35
age 60.3±10.2 64.3±10.1 0.08
sex (women) 11 (31%) 11 (31%) 1.00
Body mass index (kg/m2) 27.1±4.71 26.1±4.09 0.22
Distance of the tumor from the anal verge (cm) 3.19±1.47 (range 1–5) 2.9±1.17 (range 1–5) 0.47
asa i-6
ii-20
iii-9
i-8
ii-19
iii-8
0.60
Preoperative neoadjuvant treatment (yes/no) 31/4 31/4 1
Type of anastomosis (stapled/hand-sewn) 29/6 30/5 0.74
Abbreviations: ASA, American Society of Anesthesiologists Classification; LaTME, laparoscopic total mesorectal excision; TaTME, transanal total mesorectal excision.
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mortality was observed in either group. Table 3 presents a 
summary of the complications.
Discussion
In our study, we showed TaTME is safe and feasible, provid-
ing similar quality of resected oncological specimens. We 
managed to achieve acceptable resection margins, as well 
as intact mesorectal fascia using both the laparoscopic and 
transanal approach.
One of the greatest drawbacks of the laparoscopic 
approach is the quality of the pathological specimens. In the 
study, we chose to set a composite endpoint assessing the 
pCRM, pDRM, and completeness of mesorectal excision 
together. Although pCRM is commonly considered the most 
important aspect for quality assessment, other components 
should not be underestimated. Abbas et al28 reported that, 
with the laparoscopic technique, there is a risk of a smaller 
pCRM, which may be inadequate for achieving a satisfac-
tory oncological outcome.29 Additionally, large-scale RCTs 
such as ACOSOG and ALACART failed to demonstrate 
noninferiority for laparoscopic surgery compared with an 
open approach.30
In the present study, with the TaTME technique, we 
obtained similar results to those from LaTME for resection 
margins, as well as pathological specimen quality. Perdawood 
et al reported on a series of 100 TaTME procedures in which 
they obtained results comparable with those of laparoscopic 
and open surgery for pCRM.18 Other authors have described 
similar results.19,31 In contrast, an initial meta-analysis of 
seven studies revealed better pCRM and lower positive pCRM 
in patients who underwent transanal technique surgeries. 
However, it used a fixed effects model for calculations, which 
may have biased the results in studies with high heterogene-
ity.32 Of note, pCRM <1 mm is a risk factor for locoregional 
recurrence, as well as distant metastasis, and pCRM >1 and 
<5 mm reduced the amount of locoregional recurrence,
but not distant metastases. Only pCRM >5 mm facilitated
diminished incidence of both distant and locoregional recur-
rence.33 pCRM <1 mm is also a negative prognostic factor for 
overall survival.34 In our patients, both techniques allowed for 
achievement of an optimal pCRM wider than 5 mm. Using
TaTME, we were able to reach a pCRM that averaged 5 mm
wider than when using the laparoscopic technique. None-
theless, the data did not reach statistical significance, likely
because of the relatively small study group size.
Another important factor in rectal cancer treatment is 
the completeness of the mesorectal excision. Intact rectal 
fascia diminishes the incidence of recurrence.21 Creavin et 
al reported in their meta-analysis that superficial damage 
of the mesorectal fascia is more common in laparoscopic 
surgery compared with the open approach.35 Additionally, 
total mesorectal excision, defined as an intact mesorectum, 
negative pCRM, and distal margin, was achieved more often 
when using open surgery.35 Of note, an acceptable mesorec-
tum, defined as intact or superficial defects of the fascia, was 
achieved in both approaches at the same rate.35 However, 
that meta-analysis included only RCTs published in 2010 
and 2015. Moreover, another meta-analysis covering 1966 
through 2016, by Pe˛dziwiatr et al, revealed no differences 
between the open and laparoscopic techniques regarding 
quality of surgical specimens and short- and long-term 
oncological outcomes.8 In our opinion, owing to better lower 
Table 2 number of complications
Clavien–Dindo grade LaTME N (%) TaTME N (%)
V 0
iV anastomotic leakage with concomitant 
sepsis (operative treatment)
1 (3)
iiib anastomotic leakage (operative 
treatment)
Postoperative ileus (operative treatment)
2 (6)
1 (3)
anastomotic leakage 2 (6)
iiia anastomotic leakage (percutaneus 
drainage of the near-anastomotic 
abscess)
1 (3) 0
ii high output stoma
anastomotic leakage (conservative 
treatment)
1 (3)
2 (6)
Postoperative ileus (conservative 
treatment)
2 (6)
i Postoperative fever of unknown origin 1 (3) Radial nerve paresis (due to prolonged 
compression on the operating table)
1 (3)
Total 8 (23) 6 (17)
Abbreviations: laTMe, laparoscopic total mesorectal excision; TaTMe, transanal total mesorectal excision.
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pelvic insight and visualization of the distal margin, TaTME 
allows the surgeon to obtain higher-quality specimens than 
does pure laparoscopy. Nevertheless, we do feel TaTME 
pushes the surgeon to seek wider margins to achieve better 
specimen quality; this could lead to dangerous complications 
such as nerve injuries or damage to surrounding organs.36,37
TaTME initially appears to be a comparable method with 
classic laparoscopy in terms of clinical outcomes, with the 
only difference being longer operating time in TaTME.17,38,39 
This burden may be resolved by using a two-team approach: 
two laparoscopic sets and two teams of surgeons, wherein 
one team is responsible for the transanal step and the other 
for the abdominal. The two-team approach is promising when 
viewed in comparison with the one-team approach. Lacy et 
al achieved an average operation time of 166 minutes using 
two teams, whereas Caycedo-Marulanda, using a one-team 
approach, averaged 283 minutes.17,40 However, a two-team 
approach requires more personnel and more surgical equip-
ment, which may be limiting factors in some units.
In our material, we had four cases of purse-string suture 
failure, which can lead to contamination of the operating 
field.41 None of those patients had bowel content spillage – a 
related complication as an abdominal abscess. Other compli-
cations were unrelated to the technique included anastomotic 
failure and bowel wall perforation, which were repaired 
intraoperatively. Other potential intraoperative difficulties 
are problems with correct dissection plane identification, 
maintaining stable peritoneum, and adjacent organ injury 
such as urethra or hypogastric plexus.42
The long-accepted advantages of minimally invasive 
techniques include shorter hospitalization time and lower 
morbidity. Importantly, though older patients in particular 
benef it from laparoscopic approaches. Minimalizing 
perioperative trauma in this group of patients is crucial 
Table 3 Outcomes assessment
LaTME TaTME P-value
Primary outcome
n (%) of patients with negative pCRM and 
pDRM and complete mesorectal excision
29/35 (83%) 30/35 (86%) 0.74
Primary outcome components
pCRM ≥1 mm 35/35 (100%) 34/35 (97%) 0.25
pDRM ≥1 mm 34/35 (97%) 35/35 (100%) 0.25
Total mesorectal excision, n (%)
Complete
nearly complete
incomplete
29/35 (83)
6/35 (17)
0/35 (0)
31/35 (89)
4/35 (11)
0/35 (0)
0.23
Secondary outcomes
surgery duration (mean) 219±45 minutes 271±63 minutes 0.00
Blood loss (mean) 113±75 ml 165±148 ml 0.07
Postoperative complications 8 (22%) 6 (17%) 0.55
serious complications (CD 3–5) 4 (11%) 3 (9%) 0.69
 aJCC stage 0–7
1–7
2–10
3–11
4–0
0–8
1–3
2–10
3–14
4–0
0.58
Pathological TNM staging
pT
0
1
2
3
4
7
6
3
19
0
8
5
3
19
0
0.93
pn
0
1
2
24
6
4
21
8
5
0.58
Abbreviations: aJCC, american Joint Committee on Cancer; laTMe, laparoscopic total mesorectal excision; pCRM, circumferential resection margin; pDRM, distal 
resection margin; TaTMe, transanal total mesorectal excision.
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because of increased comorbidities. The laparoscopic 
approach lowers not only perioperative complication rates 
but also overall mortality.43 Additionally, a combination of 
minimally invasive techniques with the ERAS protocol allows 
for further improvement in recovery and outcomes.44,45
Our study has several clear limitations. First, the study 
group is small, which could increase the chance for type 
II errors; thus, it is obviously underpowered. However, to 
prove the advance of the TaTME technique, a considerably 
large group is required, as was calculated by the COLOR III 
designers. A group of 732 cases with randomization of 2:1 
is needed to demonstrate the superiority of a new technique 
over LaTME.5 It would take a great deal of time to collect 
such a large amount of cases; therefore, only an RCT may 
deliver substantive evidence. Moreover, TaTME is a new 
technique that requires a specific procedural surgeon and 
institutional experience.46,47 Koedam et al calculated that at 
least 40 cases are required for a surgeon to become profi-
cient.46 After exclusion of the first 10 cases, our group had 
34 participants; however, we analyzed patients only with 
low rectal cancer, and cases operated because of mid rectal 
cancer (5–10 cm from the anal verge) were also excluded. 
We realize that including patients during the learning curve 
period may bias the outcomes. The resolution to this problem 
is multicenter RCTs with external-quality auditing. RCTs 
comparing laparoscopic and TaTME have already begun. 
In 2016, COLOR III was launched. This is a well-designed 
and properly sampled trial with endpoints focusing on 
long-term outcomes.5 Our department participates in this. 
Other trials were also launched, such as ETAP-GRECCAR 
11 and another designed by the TAU-TEM study group.48,49 
Those studies’ results will be published over the next several 
years; therefore, until that time, we need to rely on data from 
smaller trials of possibly lower quality, which nevertheless 
provide valuable insight on the topic, with relatively low risk 
of bias. The other limitation is that the study was designed 
as case-matched. We were unable to find perfect matches; 
therefore, the patients in TaTME group were older than in 
LaTME group. We also realize that in such a small group of 
patients, this may create bias. BMI in the LaTME group was 
also slightly higher than in the TaTME group, which was also 
a result of imperfect matching, though the difference was 
small and not statistically significant.
Conclusion
TaTME appears to be noninferior to laparoscopic surgery, 
although the current data are still insufficient to fully validate 
the technique. TaTME provides surgeons an option for qual-
ity retrieval of surgical specimens with comparable clinical 
outcomes with LaTME. However, data from large RCTs are 
still necessary to confirm this method as a gold standard in 
rectal cancer surgery.
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